{"ticker": {"uuid": "8c8037d0-d1b8-4cfa-a0e9-b0ea8f7cfb2f", "symbol": "BLFS", "name": "BioLife Solutions Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "BioLife Solutions (NASDAQ: BLFS) EVP has 516 shares withheld for taxes", "summary": "Mathew Aby J., EVP & Chief Scientific Officer of BioLife Solutions (NASDAQ: BLFS), reported a tax-withholding disposition of 516 shares of common stock on July 7, 2026. The shares, valued at $27.79 each, were withheld by the company to cover tax obligations arising from the relea", "url": "https://www.stocktitan.net/sec-filings/BLFS/form-4-biolife-solutions-inc-insider-trading-activity-4b74796540a6.html", "source_name": "Stock Titan", "published_at": "2026-07-13T21:09:34", "published_display": "13 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) CFO has 844 shares withheld for RSU taxes", "summary": "BioLife Solutions' CFO, Troy Wichterman, had 844 shares of common stock withheld by the company to cover tax obligations arising from the release of restricted stock units. This transaction, valued at $27.79 per share, was a tax-withholding disposition and not an open market sale", "url": "https://www.stocktitan.net/sec-filings/BLFS/form-4-biolife-solutions-inc-insider-trading-activity-c457e891ded2.html", "source_name": "Stock Titan", "published_at": "2026-07-13T21:09:34", "published_display": "13 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) Holds Near Support Amid Consolidation - Jelly Roll Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOY2JRcE9XbGFEQ2xRZW5KRFI1aTAtdlZBbFQtTktxTUFVeTdmaVl2d0wyYXF3Tlk4VGp5YWlCYnVBLXRabjBSMnBfUWxkbGdUdkdyc1hvbjVoNmVqejktSk1jTFhWWWdIbG4xUUFwcGNnMVhDMVlEc21yVEJjbzNMblNJVGRqTjhpSE40Ukg3b0k4OG1DVW83OURxRkVvUUVjc0gw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-13T19:46:06+00:00", "published_display": "13 Jul 2026 19:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3 Stocks That May Be Trading At A Discount Of Up To 45.8% Below Intrinsic Value Estimates", "summary": "This article identifies three U.S. stocks\u2014BioLife Solutions (BLFS), Mission Produce (AVO), and OceanFirst Financial (OCFC)\u2014that are estimated to be trading below their intrinsic values based on future cash flow. Each company's operations, estimated discount, and growth forecasts ", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-blfs/biolife-solutions/news/3-stocks-that-may-be-trading-at-a-discount-of-up-to-458-belo", "source_name": "Simply Wall Street", "published_at": "2026-07-13T17:09:34", "published_display": "13 Jul 2026 17:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) After Russell Index Inclusion And The Fair Value Debate", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-09T05:02:36+00:00", "published_display": "09 Jul 2026 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Broad Russell Value Index Inclusion Will Impact BioLife Solutions (BLFS) Investors", "summary": "BioLife Solutions (BLFS) was recently added to several Russell value-oriented indices, including the Russell 2000 Value. This inclusion is expected to boost the company's visibility among institutional investors and increase liquidity, though it doesn't alter the fundamental near", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-blfs/biolife-solutions/news/how-broad-russell-value-index-inclusion-will-impact-biolife", "source_name": "Simply Wall Street", "published_at": "2026-07-07T16:12:43", "published_display": "07 Jul 2026 16:12", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BLFS - Biolife Solutions Inc Options", "summary": "This article provides comprehensive financial data and stock performance metrics for Biolife Solutions Inc. (BLFS), including its last close price, market capitalization, income, sales, key financial ratios, EPS, and insider/institutional ownership details. It also features vario", "url": "https://finviz.com/stock?t=BLFS&ta=1&p=d&ty=oc&b=2&ov=chain_strike&s=22.5", "source_name": "Finviz", "published_at": "2026-07-03T22:41:53", "published_display": "03 Jul 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q3 2025 BioLife Solutions Inc Earnings Call Transcript", "summary": "BioLife Solutions Inc. reported strong Q3 2025 results with a 33% year-over-year increase in cell processing revenue and a 31% increase in total revenue. The company raised its full-year 2025 revenue guidance and improved its balance sheet with a $25 million sale, leading to adju", "url": "https://www.gurufocus.com/stock/STU:BJX1/transcripts/3194029", "source_name": "GuruFocus", "published_at": "2026-07-02T10:12:29", "published_display": "02 Jul 2026 10:12", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does BioLife Solutions\u2019 (BLFS) Russell Value Index Debut Recast Its Cell and Gene Therapy Narrative?", "summary": "BioLife Solutions (BLFS) was recently added to several Russell value-oriented indices, which is expected to increase its visibility among institutional investors. This inclusion, however, does not alter the company's core strategy of converting embedded products into recurring re", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-blfs/biolife-solutions/news/does-biolife-solutions-blfs-russell-value-index-debut-recast", "source_name": "Simply Wall Street", "published_at": "2026-06-30T11:10:53", "published_display": "30 Jun 2026 11:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions, Inc.(NasdaqCM:BLFS) added to Russell Microcap Value Benchmark Index", "summary": "BioLife Solutions, Inc. (NasdaqCM:BLFS), a developer and supplier of cell processing tools and services for the cell and gene therapy market, has been added to the Russell Microcap Value Benchmark Index. The company provides solutions like CryoStor freeze media and HypoThermosol ", "url": "https://www.marketscreener.com/news/biolife-solutions-inc-nasdaqcm-blfs-added-to-russell-microcap-value-benchmark-index-ce7f5fded08cfe26", "source_name": "marketscreener.com", "published_at": "2026-06-29T12:57:00", "published_display": "29 Jun 2026 12:57", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions, Inc.(NasdaqCM: BLFS) added to Russell 2000 Value Benchmark", "summary": "BioLife Solutions, Inc. (NasdaqCM: BLFS) has been added to the Russell 2000 Value Benchmark Index, as announced on June 29, 2026. This news follows the company's recent addition to the Russell Microcap Value Benchmark Index. The article also provides recent financial performance,", "url": "https://www.marketscreener.com/news/biolife-solutions-inc-nasdaqcm-blfs-added-to-russell-2000-value-benchmark-ce7f5fded18ff524", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T11:41:29", "published_display": "29 Jun 2026 11:41", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) Joins Multiple Russell Value Indexes At Once", "summary": "BioLife Solutions (BLFS) has been included in several Russell Value Benchmark indexes, a development likely to influence institutional and index-tracking funds' approach to the stock. The company's shares have shown strong short-term momentum with a 15.0% return over the past mon", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-blfs/biolife-solutions/news/biolife-solutions-blfs-joins-multiple-russell-value-indexes", "source_name": "Simply Wall Street", "published_at": "2026-06-29T10:41:29", "published_display": "29 Jun 2026 10:41", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of BioLife Solutions, Inc. \u2013 NASDAQ:BLFS", "summary": "This article provides financial information for BioLife Solutions, Inc. (NASDAQ: BLFS), focusing on its price-to-earnings forward metric. The content highlights the company's financial data, market performance on Nasdaq, and general overview within the health technology sector.", "url": "https://www.tradingview.com/symbols/NASDAQ-BLFS/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T08:10:53", "published_display": "28 Jun 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of BioLife Solutions, Inc. \u2013 NASDAQ:BLFS", "summary": "This article focuses on the enterprise value to EBITDA forward for BioLife Solutions, Inc. (NASDAQ: BLFS). It appears to be a financial data snippet from TradingView, indicating a period, value, and change associated with this financial metric.", "url": "https://www.tradingview.com/symbols/NASDAQ-BLFS/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T22:41:54", "published_display": "27 Jun 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) Attracts Buyout Interest, Shares Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNS2ZXVi1mWFh1RTFzYzBTTzc1amRFZnI4T2hNSXZ1Vmp6eEZHUEpTN2ZfYkh4R0g1VVg3MUVRdFR6TzV2eEVEamp4QTI5cmp4MVc4bXc5bkxpbjUwWFlzbU51N2xtLVo4MEhqY1BMUVdwTzRzQy1ueGgxMFRkOHR4NE5nWlZ2ZDFzMm8tR3hhYVJIZFgtc3FUZVoxS3MzZ1E5?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-27T17:17:28+00:00", "published_display": "27 Jun 2026 17:17", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of BioLife Solutions, Inc. \u2013 NASDAQ:BLFS", "summary": "This article provides financial information for BioLife Solutions, Inc. (NASDAQ: BLFS), specifically focusing on its enterprise value to forward revenue. It highlights that this data and other financial metrics are available on TradingView, which serves as a platform for market d", "url": "https://www.tradingview.com/symbols/NASDAQ-BLFS/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T18:09:27", "published_display": "27 Jun 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biolife Solutions stock hits 52-week high at 29.67 USD", "summary": "BioLife Solutions Inc. (BLFS) stock reached a new 52-week high of $29.67, with its current trading price at $29.77 and a market capitalization of $1.44 billion. The company has seen a 32.53% increase in stock value over the past year and reported impressive Q1 2026 earnings with ", "url": "https://www.investing.com/news/company-news/biolife-solutions-stock-hits-52week-high-at-2967-usd-93CH-4763110", "source_name": "Investing.com", "published_at": "2026-06-27T08:40:41", "published_display": "27 Jun 2026 08:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions, Inc. Actuals & Estimates (SWB:BJX1)", "summary": "This article provides detailed financial actuals and analyst estimates for BioLife Solutions, Inc. (SWB: BJX1), covering income statements, balance sheets, cash flow, and valuation metrics. It highlights future price predictions, historical price records, upcoming earnings report", "url": "https://www.tradingview.com/symbols/SWB-BJX1/forecast-actuals-and-estimates/?category=balance_sheet", "source_name": "TradingView", "published_at": "2026-06-27T07:09:28", "published_display": "27 Jun 2026 07:09", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of BioLife Solutions, Inc. \u2013 LSX:A1XCF2", "summary": "The article provides financial information for BioLife Solutions, Inc. (A1XCF2) on the Lang & Schwarz Exchange, specifically focusing on its price-to-book forward metric. It appears to be a stub or a section from a larger financial data platform, indicating key financial data poi", "url": "https://www.tradingview.com/symbols/LSX-A1XCF2/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T04:11:16", "published_display": "27 Jun 2026 04:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions, Inc. Actuals & Estimates (LS:A1XCF2)", "summary": "This article provides an overview of BioLife Solutions, Inc. (A1XCF2) 's financial actuals and estimates, including its current stock price, market capitalization, earnings, and revenue. It details analyst forecasts, historical price performance, and key financial metrics like EB", "url": "https://www.tradingview.com/symbols/LS-A1XCF2/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T00:40:14", "published_display": "27 Jun 2026 00:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions, Inc. Actuals & Estimates (NASDAQ:BLFS)", "summary": "This article provides key financial actuals and estimates for BioLife Solutions, Inc. (BLFS), including its current stock price, historical performance, analyst forecasts, and recent earnings data. It highlights the company's valuation metrics, revenue, net income, and market cap", "url": "https://www.tradingview.com/symbols/NASDAQ-BLFS/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T23:10:30", "published_display": "25 Jun 2026 23:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BLFS Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "BioLife Solutions, Inc. (BLFS) stock currently trades at $27.50, with analysts providing a 1-year price target ranging from $30.00 to $34.00, and a consensus target of $32.30. The company has seen significant stock increases in the past year and expects its next earnings report o", "url": "https://www.tradingview.com/symbols/NASDAQ-BLFS/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T16:10:09", "published_display": "25 Jun 2026 16:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Behavioral Patterns of BLFS and Institutional Flows", "summary": "Biolife Solutions Inc. (NASDAQ: BLFS) is showing weak near and mid-term sentiment, with a neutral long-term outlook. An exceptional 44.4:1 risk-reward short setup is identified, targeting a 13.4% downside with only 0.3% risk. AI models have generated three trading strategies: a L", "url": "https://news.stocktradersdaily.com/news_release/10/Behavioral_Patterns_of_BLFS_and_Institutional_Flows_062526035202_1782373922.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-25T03:41:15", "published_display": "25 Jun 2026 03:41", "sentiment": "negative", "sentiment_pct": 39, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) CFO reports 937-share tax withholding, holds 214K shares", "summary": "BioLife Solutions CFO Troy Wichterman had 937 shares withheld to cover tax obligations related to the release of restricted stock units. This transaction, valued at $26.04 per share, was a routine tax settlement, not an open-market sale. After the withholding, Wichterman directly", "url": "https://www.stocktitan.net/sec-filings/BLFS/form-4-biolife-solutions-inc-insider-trading-activity-438e3abaed38.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:09:28", "published_display": "23 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 BioLife Solutions Inc For: 22 June By Investing.com", "summary": "This article from Investing.com reports on a Form 4 filing for BioLife Solutions Inc. dated June 22. It indicates the stock symbol BLFS and notes a 3.15% increase. The content appears to be primarily an announcement of the filing rather than an in-depth analysis.", "url": "https://za.investing.com/news/stock-market-news/form-4-biolife-solutions-inc-for-22-june-93CH-4338708", "source_name": "Investing.com South Africa", "published_at": "2026-06-23T06:40:18", "published_display": "23 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) CEO reports RSU tax share withholding", "summary": "BioLife Solutions' President and CEO, Roderick De Greef, had 2,775 shares of common stock withheld by the company to cover tax obligations stemming from the release of restricted stock units. This was a non-market transaction for tax purposes, not a sale. Following this withholdi", "url": "https://www.stocktitan.net/sec-filings/BLFS/form-4-biolife-solutions-inc-insider-trading-activity-ef8a53e82821.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:41:00", "published_display": "22 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] BIOLIFE SOLUTIONS INC Insider Trading Activity", "summary": "BIOLIFE SOLUTIONS INC's Chief Technology Officer, Sean Werner, reported a disposition of 420 shares of Common Stock at $26.04 per share. This transaction was not an open-market trade but shares withheld by the company to cover tax withholding obligations related to restricted sto", "url": "https://www.stocktitan.net/sec-filings/BLFS/form-4-biolife-solutions-inc-insider-trading-activity-a3c277aacafd.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:41:00", "published_display": "22 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) CMO has 470 shares withheld to cover RSU tax bill", "summary": "BioLife Solutions' Chief Marketing Officer, Todd Berard, had 470 shares of common stock withheld by the company to cover tax obligations related to the vesting of his restricted stock units (RSUs). This transaction, which is a tax-withholding disposition and not an open-market sa", "url": "https://www.stocktitan.net/sec-filings/BLFS/form-4-biolife-solutions-inc-insider-trading-activity-940feae1eab9.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:41:00", "published_display": "22 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) Stock Could Be 19.7% Undervalued After Portfolio Re Entry", "summary": "BioLife Solutions (BLFS) has been re-added to Prosper Stars & Stripes' portfolio, highlighting its focus on biopreservation and cell/gene therapy. The stock has seen significant short-term gains, with analysts suggesting it could be 19.7% undervalued at $32.44 compared to its cur", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-blfs/biolife-solutions/news/biolife-solutions-blfs-stock-could-be-197-undervalued-after", "source_name": "Simply Wall Street", "published_at": "2026-06-22T07:10:09", "published_display": "22 Jun 2026 07:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions Inc (BLFS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a brief overview of BioLife Solutions Inc (BLFS), including its stock price, market cap, and a partial revenue breakdown. The revenue breakdown shows regional contributions for recent periods, with the United States accounting for 80% of revenue, Europe & Mi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-blfs/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T21:13:14", "published_display": "18 Jun 2026 21:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Makes BioLife Solutions (BLFS) a Compelling Long-Term Hold?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNZldyd2JoUVlZUUdIWkwyOGZHUU9wNGJLWFNIdzRobkxhRFQ0aUtLRFk3M0hvQW5nREF0cXYzQ01INUxYTmFaSDdXOVozS0ZKLUZjY1BFN0ptcFJ6bmZxOWRpR3lOZTlRZUUxdHdudnNnR0MwYVhISWdQeGppLVVWZUE3NkJjVm1nQVBTY2drWDVfUTZQajRYSkFKWXF5TmYxcUE?oc=5", "source_name": "Market source", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions Leads 3 Stocks Estimated To Be Trading Below Fair Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPeEJoeUdPaWFiZTl6SHVyVlZ6WHlYTkd1V1BiLUZESXJ0Z253cmNNd0Z4TWQ4OXF2bmNxRl9rdE5MQWtqaXc0R0VKaEViX3cxNDdBWU1FaFhTc2xKVTlaTG9zSWI0ZnU3SnBMQVB2SnBMYXlyeExvUXd4UnZuc1oteGJWLV9FSUV2dmpUMThBLWg0YVQwbUE1WHBDRmp5UQ?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Casdin Capital, Eli Casdin sell $28.1m in NASDAQ:BLFS stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOWGdPSURYWDZaSkV6OWxqZG9mbU54aWlmZGxNYU9ETDRrN3NCVVJrSFptR3FQZnlfTVJKNUt0d2xCcWQxMEJpZktadzhKblZidzc1LVNMYnZNczA5V3cxWlAtbzBjOFR1VjBDbklGUEpFcW1rTW5pTXNtX0ZvRm5JaTNQcXN3dU10RVpKZ3lnZTVhY0J0aG5RbDk2MEswWGRlOFJHX254OU9YX1RLVDJpUk9KVnZKRFVrVEpqYQ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At BioLife Solutions (BLFS) Valuation As Shares Show Recent Short Term Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNYWdOdzBrWFpoMEQxNzlaak9HMExPRU1URVdZNGJtT1UxTWtIdnJOUjV0eEt3MERMbGFOaTAxMXktbW83VDBTWUdIM2RfSEF3bEEyNXREcDBmbEppTFFKOXo5OGZLdmZoWWxvLVBCc3ZGZDdUZ2JjZmJPbU5JTFNFZENJWWFLNmpDa0Z1cl9aMlUyaWpQYWg5RjRDUlhpVzBCQUVFNQ?oc=5", "source_name": "Market source", "published_at": "2026-05-10T07:00:00+00:00", "published_display": "10 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife (BLFS) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/89a56aeb-2ad6-30ad-84f2-870abb7d606e/biolife-%28blfs%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-08T14:21:18+00:00", "published_display": "08 May 2026 14:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/3c98d033-0a12-3942-9de3-32d236b6daf0/biolife-solutions%2C-inc.-q1.html", "source_name": "Moby", "published_at": "2026-05-08T12:30:00+00:00", "published_display": "08 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/58567dc0-d37e-3304-bc30-0510bccd8fb3/biolife-solutions-q1-earnings.html", "source_name": "MarketBeat", "published_at": "2026-05-07T21:39:36+00:00", "published_display": "07 May 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: BioLife Solutions Q1 2026: Revenue Surges, Stock Rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQOE1UcWxydmtPMEdicFdndlpsVjIwbEhuYVEtN185Q0Qxa1ZzVVZqUngzdklZZW52OF9kdzA2S0hMeDU4Z1J0YVpYUXhBZ2JKak5GY2U1cjFpc1BRNG9xNE00Wmp0d1NlWG1FUmVDU1hXSlJSdWY3V1Fpa3I1c1JhY3U2WGlRZmx3YTJfMms2b29GLUFxeUdsZ0x1bUc3Zy1IRXFMbUcwdHVVTTNmUFk2RlFzRHJiem1TQ2xRWDR4eVVEMm9FUHVFOEw3ZWRGdw?oc=5", "source_name": "Investing.com", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions, Inc. (BLFS) Tops Q1 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOVlVFNGd6OWtKMzI2OUJjblVBLTVWa05NcjE4eVVhVWJkNDZjczNjOGxjWXlFN2d1MWZKaXZfaFlvSm1ybmppYUJqZ2tZeEd5aEFhdXdRYVRUd09nalIzRjBLYm0wOTR5TGlTOXE5d3NrVkNlZnkzZzJKTFV4WE1QVGhTY0RYa0ZaMDBUTVpwU0tLcnhieG9qS21jeGQ?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPUFJDa2pQOEpxSGgtUnNaeGtNTGh1ZlFFWEVJNVl4Y3ZIXzVaR3NQbVNNNVJjU3lpVXJ2dlQtcFZEY2hyVkgxLVpsd1ZEaXJod3NaTlhaT1FlSDlaVUxVdHQ4Q3NPRERLcGR6NDhVbXhDeGpKakhEd2VxRzhSMVpHMThZaklQRUJCYkpmQ2JaaFVJeTFrM0NIOFBqMTFNWTd0TW0xSFZ6M1psUS14dnJsMmxPc0lJLUJEbXc?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (NASDAQ: BLFS) grows Q1 2026 revenue 25%", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNWmRqRTlOQnFZck9TZWNLQ0xYalhFeVNYUDFYM2NJcDBpc3VrYWdVTmRmQW0teFh3cFlwX01MaW5pVDV6OXZJNTl2R2V2ejhtc3Uzc1BHMjNzUXJhMjRxYnVGckRQVFlfSTVvMElEbTdTemNELVdrZmgxbU5HRi01TTRvN1gtcEFURVpLamUzbGRBR1ZFR082N1JhOHNfN245QzJEcFE5YmdLbEVha25j?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Discover BioLife Solutions And 2 Other Stocks That May Be Priced Below Their Estimated Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOOXoxYWhlV1RRaFhvSzFuRGl2WnBuN0E5emI0QmlqNzJhQmhSQVNoRWllVlNnTGoxM1pxSEVRbGU4emN4S1lXM2lZajM4X1Y4QXRxTFpfMy1Rdks2Wk9pbTFPZ2FaY01RVHdwa0ZoaElFYTBDNkNjbGpyMFJ3am9HV2k2ejJGTm5pRDV4d0hSQ2RqVzR4VGM1SHRwNGhHc19z?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After Plunging 17.6% in 4 Weeks, Here's Why the Trend Might Reverse for BioLife Solutions (BLFS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTFB1TFlhXzNvSHE0cjlZcnUzZzNCUlNhMXlNcWxUdnhSbmdIcWFmTVNUTURQQlR4OFB4X2dmOWgxaEk4ZEdldldNWV92eU0zZ21ubE53UkJiY2xIaTJKWmJlbFY5YzZhWEprNzhERzJkUnNwbUNjRVE?oc=5", "source_name": "Market source", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxORnd1aDBlLVRRREUtQnkzczlBd3piMWVzQjhVM2dhLXdvZDktQmUxZXdhUENSaFlTNjhRRzVhbU9wRFhhN1E1elJtdjNKSmpnLVJJM2M3RkZfSV9ocHVJaE82aWZXRnFWcFFNZ3pCVERCOVFDMlc5ZnRJalQ5Y1h2TWtSZFNNdklTWlhzdFNnQVE0NExPdWtDb0hESEJPUFM1dzhRQnJjYl9SYTEzNGQxOG1WdHpSSFh3TnEwWFNxcUFkQXdvMGoxVkh3b0NlREdGQUZFMVdqbW53c192Q0FSV3l0NE9oQWZnYUZHSFpQZmNVdw?oc=5", "source_name": "PR Newswire", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biolife Solutions (BLFS) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE8xTlNtX0hkdzhPbk9GZjZEUlZMNXQtd0hhUmZpRUlsTHdJSUxLTW9lN2Fjalg5RDRRek5ub1N2WFZWcmNDbWxWRlVhMUNGMDJxUTZJ?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T22:13:08+00:00", "published_display": "24 Apr 2025 22:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biolife solutions CHRO Sarah Aebersold sells $5,875 in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNdlMwNm1oWTZ4R3k3RVZVc0dWVkUyZ1RlZURQcXhvQkNsVExIRGNKc0FPYXZWMlZZNlFqcGttNzhnQXZjeWsxRzYtSy1Qak1STW5iT2w2VFZIRzJDdGV6OVJRSjlrMVE4eWJiMmtVanJzZjYycFU2Y3A3UUVSczdEMXdUQ0RFbEFNX1BFUW14S2FWa0lsNFVvX19uNWoteERzdE5TRDR6bUludEg2Y1BHRTlUaDdRdHVHcjF3MXhWb3E?oc=5", "source_name": "Investing.com", "published_at": "2024-11-29T08:00:00+00:00", "published_display": "29 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Plasma Services to open donation center in Georgetown", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNcEtRNDlmZ3QyQ2JoU2Jqa1ktVlloY010OVhSR0Y5ZTAwT09vd241TVRyY0d1MXlyZm1odG4wWnpzRzVtMzluSFJ1TGhZbG9FejZTYm52YU01Y3FYcXpMMnNiNWpRWlZNNkV0N1E4dHBRRHV6X3dFWm9QT0tXRWF4TjJoU08wQkttQWdOUHktOFZRUV9wZl8xZXU2M1dPNGszd1dkUFZsUzJMTXVMMEl3?oc=5", "source_name": "Community Impact", "published_at": "2024-08-23T07:00:00+00:00", "published_display": "23 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "BioLife Solutions (NASDAQ: BLFS) EVP has 516 shares withheld for taxes", "summary": "Mathew Aby J., EVP & Chief Scientific Officer of BioLife Solutions (NASDAQ: BLFS), reported a tax-withholding disposition of 516 shares of common stock on July 7, 2026. The shares, valued at $27.79 each, were withheld by the company to cover tax obligations arising from the relea", "url": "https://www.stocktitan.net/sec-filings/BLFS/form-4-biolife-solutions-inc-insider-trading-activity-4b74796540a6.html", "source_name": "Stock Titan", "published_at": "2026-07-13T21:09:34", "published_display": "13 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) CFO has 844 shares withheld for RSU taxes", "summary": "BioLife Solutions' CFO, Troy Wichterman, had 844 shares of common stock withheld by the company to cover tax obligations arising from the release of restricted stock units. This transaction, valued at $27.79 per share, was a tax-withholding disposition and not an open market sale", "url": "https://www.stocktitan.net/sec-filings/BLFS/form-4-biolife-solutions-inc-insider-trading-activity-c457e891ded2.html", "source_name": "Stock Titan", "published_at": "2026-07-13T21:09:34", "published_display": "13 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) Holds Near Support Amid Consolidation - Jelly Roll Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOY2JRcE9XbGFEQ2xRZW5KRFI1aTAtdlZBbFQtTktxTUFVeTdmaVl2d0wyYXF3Tlk4VGp5YWlCYnVBLXRabjBSMnBfUWxkbGdUdkdyc1hvbjVoNmVqejktSk1jTFhWWWdIbG4xUUFwcGNnMVhDMVlEc21yVEJjbzNMblNJVGRqTjhpSE40Ukg3b0k4OG1DVW83OURxRkVvUUVjc0gw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-13T19:46:06+00:00", "published_display": "13 Jul 2026 19:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3 Stocks That May Be Trading At A Discount Of Up To 45.8% Below Intrinsic Value Estimates", "summary": "This article identifies three U.S. stocks\u2014BioLife Solutions (BLFS), Mission Produce (AVO), and OceanFirst Financial (OCFC)\u2014that are estimated to be trading below their intrinsic values based on future cash flow. Each company's operations, estimated discount, and growth forecasts ", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-blfs/biolife-solutions/news/3-stocks-that-may-be-trading-at-a-discount-of-up-to-458-belo", "source_name": "Simply Wall Street", "published_at": "2026-07-13T17:09:34", "published_display": "13 Jul 2026 17:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) After Russell Index Inclusion And The Fair Value Debate", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-09T05:02:36+00:00", "published_display": "09 Jul 2026 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Broad Russell Value Index Inclusion Will Impact BioLife Solutions (BLFS) Investors", "summary": "BioLife Solutions (BLFS) was recently added to several Russell value-oriented indices, including the Russell 2000 Value. This inclusion is expected to boost the company's visibility among institutional investors and increase liquidity, though it doesn't alter the fundamental near", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-blfs/biolife-solutions/news/how-broad-russell-value-index-inclusion-will-impact-biolife", "source_name": "Simply Wall Street", "published_at": "2026-07-07T16:12:43", "published_display": "07 Jul 2026 16:12", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BLFS - Biolife Solutions Inc Options", "summary": "This article provides comprehensive financial data and stock performance metrics for Biolife Solutions Inc. (BLFS), including its last close price, market capitalization, income, sales, key financial ratios, EPS, and insider/institutional ownership details. It also features vario", "url": "https://finviz.com/stock?t=BLFS&ta=1&p=d&ty=oc&b=2&ov=chain_strike&s=22.5", "source_name": "Finviz", "published_at": "2026-07-03T22:41:53", "published_display": "03 Jul 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q3 2025 BioLife Solutions Inc Earnings Call Transcript", "summary": "BioLife Solutions Inc. reported strong Q3 2025 results with a 33% year-over-year increase in cell processing revenue and a 31% increase in total revenue. The company raised its full-year 2025 revenue guidance and improved its balance sheet with a $25 million sale, leading to adju", "url": "https://www.gurufocus.com/stock/STU:BJX1/transcripts/3194029", "source_name": "GuruFocus", "published_at": "2026-07-02T10:12:29", "published_display": "02 Jul 2026 10:12", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does BioLife Solutions\u2019 (BLFS) Russell Value Index Debut Recast Its Cell and Gene Therapy Narrative?", "summary": "BioLife Solutions (BLFS) was recently added to several Russell value-oriented indices, which is expected to increase its visibility among institutional investors. This inclusion, however, does not alter the company's core strategy of converting embedded products into recurring re", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-blfs/biolife-solutions/news/does-biolife-solutions-blfs-russell-value-index-debut-recast", "source_name": "Simply Wall Street", "published_at": "2026-06-30T11:10:53", "published_display": "30 Jun 2026 11:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions, Inc.(NasdaqCM:BLFS) added to Russell Microcap Value Benchmark Index", "summary": "BioLife Solutions, Inc. (NasdaqCM:BLFS), a developer and supplier of cell processing tools and services for the cell and gene therapy market, has been added to the Russell Microcap Value Benchmark Index. The company provides solutions like CryoStor freeze media and HypoThermosol ", "url": "https://www.marketscreener.com/news/biolife-solutions-inc-nasdaqcm-blfs-added-to-russell-microcap-value-benchmark-index-ce7f5fded08cfe26", "source_name": "marketscreener.com", "published_at": "2026-06-29T12:57:00", "published_display": "29 Jun 2026 12:57", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions, Inc.(NasdaqCM: BLFS) added to Russell 2000 Value Benchmark", "summary": "BioLife Solutions, Inc. (NasdaqCM: BLFS) has been added to the Russell 2000 Value Benchmark Index, as announced on June 29, 2026. This news follows the company's recent addition to the Russell Microcap Value Benchmark Index. The article also provides recent financial performance,", "url": "https://www.marketscreener.com/news/biolife-solutions-inc-nasdaqcm-blfs-added-to-russell-2000-value-benchmark-ce7f5fded18ff524", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T11:41:29", "published_display": "29 Jun 2026 11:41", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) Joins Multiple Russell Value Indexes At Once", "summary": "BioLife Solutions (BLFS) has been included in several Russell Value Benchmark indexes, a development likely to influence institutional and index-tracking funds' approach to the stock. The company's shares have shown strong short-term momentum with a 15.0% return over the past mon", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-blfs/biolife-solutions/news/biolife-solutions-blfs-joins-multiple-russell-value-indexes", "source_name": "Simply Wall Street", "published_at": "2026-06-29T10:41:29", "published_display": "29 Jun 2026 10:41", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of BioLife Solutions, Inc. \u2013 NASDAQ:BLFS", "summary": "This article provides financial information for BioLife Solutions, Inc. (NASDAQ: BLFS), focusing on its price-to-earnings forward metric. The content highlights the company's financial data, market performance on Nasdaq, and general overview within the health technology sector.", "url": "https://www.tradingview.com/symbols/NASDAQ-BLFS/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T08:10:53", "published_display": "28 Jun 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of BioLife Solutions, Inc. \u2013 NASDAQ:BLFS", "summary": "This article focuses on the enterprise value to EBITDA forward for BioLife Solutions, Inc. (NASDAQ: BLFS). It appears to be a financial data snippet from TradingView, indicating a period, value, and change associated with this financial metric.", "url": "https://www.tradingview.com/symbols/NASDAQ-BLFS/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T22:41:54", "published_display": "27 Jun 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) Attracts Buyout Interest, Shares Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNS2ZXVi1mWFh1RTFzYzBTTzc1amRFZnI4T2hNSXZ1Vmp6eEZHUEpTN2ZfYkh4R0g1VVg3MUVRdFR6TzV2eEVEamp4QTI5cmp4MVc4bXc5bkxpbjUwWFlzbU51N2xtLVo4MEhqY1BMUVdwTzRzQy1ueGgxMFRkOHR4NE5nWlZ2ZDFzMm8tR3hhYVJIZFgtc3FUZVoxS3MzZ1E5?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-27T17:17:28+00:00", "published_display": "27 Jun 2026 17:17", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of BioLife Solutions, Inc. \u2013 NASDAQ:BLFS", "summary": "This article provides financial information for BioLife Solutions, Inc. (NASDAQ: BLFS), specifically focusing on its enterprise value to forward revenue. It highlights that this data and other financial metrics are available on TradingView, which serves as a platform for market d", "url": "https://www.tradingview.com/symbols/NASDAQ-BLFS/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T18:09:27", "published_display": "27 Jun 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biolife Solutions stock hits 52-week high at 29.67 USD", "summary": "BioLife Solutions Inc. (BLFS) stock reached a new 52-week high of $29.67, with its current trading price at $29.77 and a market capitalization of $1.44 billion. The company has seen a 32.53% increase in stock value over the past year and reported impressive Q1 2026 earnings with ", "url": "https://www.investing.com/news/company-news/biolife-solutions-stock-hits-52week-high-at-2967-usd-93CH-4763110", "source_name": "Investing.com", "published_at": "2026-06-27T08:40:41", "published_display": "27 Jun 2026 08:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions, Inc. Actuals & Estimates (SWB:BJX1)", "summary": "This article provides detailed financial actuals and analyst estimates for BioLife Solutions, Inc. (SWB: BJX1), covering income statements, balance sheets, cash flow, and valuation metrics. It highlights future price predictions, historical price records, upcoming earnings report", "url": "https://www.tradingview.com/symbols/SWB-BJX1/forecast-actuals-and-estimates/?category=balance_sheet", "source_name": "TradingView", "published_at": "2026-06-27T07:09:28", "published_display": "27 Jun 2026 07:09", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of BioLife Solutions, Inc. \u2013 LSX:A1XCF2", "summary": "The article provides financial information for BioLife Solutions, Inc. (A1XCF2) on the Lang & Schwarz Exchange, specifically focusing on its price-to-book forward metric. It appears to be a stub or a section from a larger financial data platform, indicating key financial data poi", "url": "https://www.tradingview.com/symbols/LSX-A1XCF2/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T04:11:16", "published_display": "27 Jun 2026 04:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions, Inc. Actuals & Estimates (LS:A1XCF2)", "summary": "This article provides an overview of BioLife Solutions, Inc. (A1XCF2) 's financial actuals and estimates, including its current stock price, market capitalization, earnings, and revenue. It details analyst forecasts, historical price performance, and key financial metrics like EB", "url": "https://www.tradingview.com/symbols/LS-A1XCF2/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T00:40:14", "published_display": "27 Jun 2026 00:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions, Inc. Actuals & Estimates (NASDAQ:BLFS)", "summary": "This article provides key financial actuals and estimates for BioLife Solutions, Inc. (BLFS), including its current stock price, historical performance, analyst forecasts, and recent earnings data. It highlights the company's valuation metrics, revenue, net income, and market cap", "url": "https://www.tradingview.com/symbols/NASDAQ-BLFS/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T23:10:30", "published_display": "25 Jun 2026 23:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BLFS Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "BioLife Solutions, Inc. (BLFS) stock currently trades at $27.50, with analysts providing a 1-year price target ranging from $30.00 to $34.00, and a consensus target of $32.30. The company has seen significant stock increases in the past year and expects its next earnings report o", "url": "https://www.tradingview.com/symbols/NASDAQ-BLFS/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T16:10:09", "published_display": "25 Jun 2026 16:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Behavioral Patterns of BLFS and Institutional Flows", "summary": "Biolife Solutions Inc. (NASDAQ: BLFS) is showing weak near and mid-term sentiment, with a neutral long-term outlook. An exceptional 44.4:1 risk-reward short setup is identified, targeting a 13.4% downside with only 0.3% risk. AI models have generated three trading strategies: a L", "url": "https://news.stocktradersdaily.com/news_release/10/Behavioral_Patterns_of_BLFS_and_Institutional_Flows_062526035202_1782373922.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-25T03:41:15", "published_display": "25 Jun 2026 03:41", "sentiment": "negative", "sentiment_pct": 39, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) CFO reports 937-share tax withholding, holds 214K shares", "summary": "BioLife Solutions CFO Troy Wichterman had 937 shares withheld to cover tax obligations related to the release of restricted stock units. This transaction, valued at $26.04 per share, was a routine tax settlement, not an open-market sale. After the withholding, Wichterman directly", "url": "https://www.stocktitan.net/sec-filings/BLFS/form-4-biolife-solutions-inc-insider-trading-activity-438e3abaed38.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:09:28", "published_display": "23 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 BioLife Solutions Inc For: 22 June By Investing.com", "summary": "This article from Investing.com reports on a Form 4 filing for BioLife Solutions Inc. dated June 22. It indicates the stock symbol BLFS and notes a 3.15% increase. The content appears to be primarily an announcement of the filing rather than an in-depth analysis.", "url": "https://za.investing.com/news/stock-market-news/form-4-biolife-solutions-inc-for-22-june-93CH-4338708", "source_name": "Investing.com South Africa", "published_at": "2026-06-23T06:40:18", "published_display": "23 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) CEO reports RSU tax share withholding", "summary": "BioLife Solutions' President and CEO, Roderick De Greef, had 2,775 shares of common stock withheld by the company to cover tax obligations stemming from the release of restricted stock units. This was a non-market transaction for tax purposes, not a sale. Following this withholdi", "url": "https://www.stocktitan.net/sec-filings/BLFS/form-4-biolife-solutions-inc-insider-trading-activity-ef8a53e82821.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:41:00", "published_display": "22 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] BIOLIFE SOLUTIONS INC Insider Trading Activity", "summary": "BIOLIFE SOLUTIONS INC's Chief Technology Officer, Sean Werner, reported a disposition of 420 shares of Common Stock at $26.04 per share. This transaction was not an open-market trade but shares withheld by the company to cover tax withholding obligations related to restricted sto", "url": "https://www.stocktitan.net/sec-filings/BLFS/form-4-biolife-solutions-inc-insider-trading-activity-a3c277aacafd.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:41:00", "published_display": "22 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) CMO has 470 shares withheld to cover RSU tax bill", "summary": "BioLife Solutions' Chief Marketing Officer, Todd Berard, had 470 shares of common stock withheld by the company to cover tax obligations related to the vesting of his restricted stock units (RSUs). This transaction, which is a tax-withholding disposition and not an open-market sa", "url": "https://www.stocktitan.net/sec-filings/BLFS/form-4-biolife-solutions-inc-insider-trading-activity-940feae1eab9.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:41:00", "published_display": "22 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (BLFS) Stock Could Be 19.7% Undervalued After Portfolio Re Entry", "summary": "BioLife Solutions (BLFS) has been re-added to Prosper Stars & Stripes' portfolio, highlighting its focus on biopreservation and cell/gene therapy. The stock has seen significant short-term gains, with analysts suggesting it could be 19.7% undervalued at $32.44 compared to its cur", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-blfs/biolife-solutions/news/biolife-solutions-blfs-stock-could-be-197-undervalued-after", "source_name": "Simply Wall Street", "published_at": "2026-06-22T07:10:09", "published_display": "22 Jun 2026 07:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions Inc (BLFS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a brief overview of BioLife Solutions Inc (BLFS), including its stock price, market cap, and a partial revenue breakdown. The revenue breakdown shows regional contributions for recent periods, with the United States accounting for 80% of revenue, Europe & Mi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-blfs/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T21:13:14", "published_display": "18 Jun 2026 21:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Makes BioLife Solutions (BLFS) a Compelling Long-Term Hold?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNZldyd2JoUVlZUUdIWkwyOGZHUU9wNGJLWFNIdzRobkxhRFQ0aUtLRFk3M0hvQW5nREF0cXYzQ01INUxYTmFaSDdXOVozS0ZKLUZjY1BFN0ptcFJ6bmZxOWRpR3lOZTlRZUUxdHdudnNnR0MwYVhISWdQeGppLVVWZUE3NkJjVm1nQVBTY2drWDVfUTZQajRYSkFKWXF5TmYxcUE?oc=5", "source_name": "Market source", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions Leads 3 Stocks Estimated To Be Trading Below Fair Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPeEJoeUdPaWFiZTl6SHVyVlZ6WHlYTkd1V1BiLUZESXJ0Z253cmNNd0Z4TWQ4OXF2bmNxRl9rdE5MQWtqaXc0R0VKaEViX3cxNDdBWU1FaFhTc2xKVTlaTG9zSWI0ZnU3SnBMQVB2SnBMYXlyeExvUXd4UnZuc1oteGJWLV9FSUV2dmpUMThBLWg0YVQwbUE1WHBDRmp5UQ?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Casdin Capital, Eli Casdin sell $28.1m in NASDAQ:BLFS stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOWGdPSURYWDZaSkV6OWxqZG9mbU54aWlmZGxNYU9ETDRrN3NCVVJrSFptR3FQZnlfTVJKNUt0d2xCcWQxMEJpZktadzhKblZidzc1LVNMYnZNczA5V3cxWlAtbzBjOFR1VjBDbklGUEpFcW1rTW5pTXNtX0ZvRm5JaTNQcXN3dU10RVpKZ3lnZTVhY0J0aG5RbDk2MEswWGRlOFJHX254OU9YX1RLVDJpUk9KVnZKRFVrVEpqYQ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At BioLife Solutions (BLFS) Valuation As Shares Show Recent Short Term Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNYWdOdzBrWFpoMEQxNzlaak9HMExPRU1URVdZNGJtT1UxTWtIdnJOUjV0eEt3MERMbGFOaTAxMXktbW83VDBTWUdIM2RfSEF3bEEyNXREcDBmbEppTFFKOXo5OGZLdmZoWWxvLVBCc3ZGZDdUZ2JjZmJPbU5JTFNFZENJWWFLNmpDa0Z1cl9aMlUyaWpQYWg5RjRDUlhpVzBCQUVFNQ?oc=5", "source_name": "Market source", "published_at": "2026-05-10T07:00:00+00:00", "published_display": "10 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife (BLFS) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/89a56aeb-2ad6-30ad-84f2-870abb7d606e/biolife-%28blfs%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-08T14:21:18+00:00", "published_display": "08 May 2026 14:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/3c98d033-0a12-3942-9de3-32d236b6daf0/biolife-solutions%2C-inc.-q1.html", "source_name": "Moby", "published_at": "2026-05-08T12:30:00+00:00", "published_display": "08 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/58567dc0-d37e-3304-bc30-0510bccd8fb3/biolife-solutions-q1-earnings.html", "source_name": "MarketBeat", "published_at": "2026-05-07T21:39:36+00:00", "published_display": "07 May 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: BioLife Solutions Q1 2026: Revenue Surges, Stock Rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQOE1UcWxydmtPMEdicFdndlpsVjIwbEhuYVEtN185Q0Qxa1ZzVVZqUngzdklZZW52OF9kdzA2S0hMeDU4Z1J0YVpYUXhBZ2JKak5GY2U1cjFpc1BRNG9xNE00Wmp0d1NlWG1FUmVDU1hXSlJSdWY3V1Fpa3I1c1JhY3U2WGlRZmx3YTJfMms2b29GLUFxeUdsZ0x1bUc3Zy1IRXFMbUcwdHVVTTNmUFk2RlFzRHJiem1TQ2xRWDR4eVVEMm9FUHVFOEw3ZWRGdw?oc=5", "source_name": "Investing.com", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions, Inc. (BLFS) Tops Q1 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOVlVFNGd6OWtKMzI2OUJjblVBLTVWa05NcjE4eVVhVWJkNDZjczNjOGxjWXlFN2d1MWZKaXZfaFlvSm1ybmppYUJqZ2tZeEd5aEFhdXdRYVRUd09nalIzRjBLYm0wOTR5TGlTOXE5d3NrVkNlZnkzZzJKTFV4WE1QVGhTY0RYa0ZaMDBUTVpwU0tLcnhieG9qS21jeGQ?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPUFJDa2pQOEpxSGgtUnNaeGtNTGh1ZlFFWEVJNVl4Y3ZIXzVaR3NQbVNNNVJjU3lpVXJ2dlQtcFZEY2hyVkgxLVpsd1ZEaXJod3NaTlhaT1FlSDlaVUxVdHQ4Q3NPRERLcGR6NDhVbXhDeGpKakhEd2VxRzhSMVpHMThZaklQRUJCYkpmQ2JaaFVJeTFrM0NIOFBqMTFNWTd0TW0xSFZ6M1psUS14dnJsMmxPc0lJLUJEbXc?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions (NASDAQ: BLFS) grows Q1 2026 revenue 25%", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNWmRqRTlOQnFZck9TZWNLQ0xYalhFeVNYUDFYM2NJcDBpc3VrYWdVTmRmQW0teFh3cFlwX01MaW5pVDV6OXZJNTl2R2V2ejhtc3Uzc1BHMjNzUXJhMjRxYnVGckRQVFlfSTVvMElEbTdTemNELVdrZmgxbU5HRi01TTRvN1gtcEFURVpLamUzbGRBR1ZFR082N1JhOHNfN245QzJEcFE5YmdLbEVha25j?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Discover BioLife Solutions And 2 Other Stocks That May Be Priced Below Their Estimated Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOOXoxYWhlV1RRaFhvSzFuRGl2WnBuN0E5emI0QmlqNzJhQmhSQVNoRWllVlNnTGoxM1pxSEVRbGU4emN4S1lXM2lZajM4X1Y4QXRxTFpfMy1Rdks2Wk9pbTFPZ2FaY01RVHdwa0ZoaElFYTBDNkNjbGpyMFJ3am9HV2k2ejJGTm5pRDV4d0hSQ2RqVzR4VGM1SHRwNGhHc19z?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After Plunging 17.6% in 4 Weeks, Here's Why the Trend Might Reverse for BioLife Solutions (BLFS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTFB1TFlhXzNvSHE0cjlZcnUzZzNCUlNhMXlNcWxUdnhSbmdIcWFmTVNUTURQQlR4OFB4X2dmOWgxaEk4ZEdldldNWV92eU0zZ21ubE53UkJiY2xIaTJKWmJlbFY5YzZhWEprNzhERzJkUnNwbUNjRVE?oc=5", "source_name": "Market source", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxORnd1aDBlLVRRREUtQnkzczlBd3piMWVzQjhVM2dhLXdvZDktQmUxZXdhUENSaFlTNjhRRzVhbU9wRFhhN1E1elJtdjNKSmpnLVJJM2M3RkZfSV9ocHVJaE82aWZXRnFWcFFNZ3pCVERCOVFDMlc5ZnRJalQ5Y1h2TWtSZFNNdklTWlhzdFNnQVE0NExPdWtDb0hESEJPUFM1dzhRQnJjYl9SYTEzNGQxOG1WdHpSSFh3TnEwWFNxcUFkQXdvMGoxVkh3b0NlREdGQUZFMVdqbW53c192Q0FSV3l0NE9oQWZnYUZHSFpQZmNVdw?oc=5", "source_name": "PR Newswire", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biolife Solutions (BLFS) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE8xTlNtX0hkdzhPbk9GZjZEUlZMNXQtd0hhUmZpRUlsTHdJSUxLTW9lN2Fjalg5RDRRek5ub1N2WFZWcmNDbWxWRlVhMUNGMDJxUTZJ?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T22:13:08+00:00", "published_display": "24 Apr 2025 22:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biolife solutions CHRO Sarah Aebersold sells $5,875 in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNdlMwNm1oWTZ4R3k3RVZVc0dWVkUyZ1RlZURQcXhvQkNsVExIRGNKc0FPYXZWMlZZNlFqcGttNzhnQXZjeWsxRzYtSy1Qak1STW5iT2w2VFZIRzJDdGV6OVJRSjlrMVE4eWJiMmtVanJzZjYycFU2Y3A3UUVSczdEMXdUQ0RFbEFNX1BFUW14S2FWa0lsNFVvX19uNWoteERzdE5TRDR6bUludEg2Y1BHRTlUaDdRdHVHcjF3MXhWb3E?oc=5", "source_name": "Investing.com", "published_at": "2024-11-29T08:00:00+00:00", "published_display": "29 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioLife Plasma Services to open donation center in Georgetown", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNcEtRNDlmZ3QyQ2JoU2Jqa1ktVlloY010OVhSR0Y5ZTAwT09vd241TVRyY0d1MXlyZm1odG4wWnpzRzVtMzluSFJ1TGhZbG9FejZTYm52YU01Y3FYcXpMMnNiNWpRWlZNNkV0N1E4dHBRRHV6X3dFWm9QT0tXRWF4TjJoU08wQkttQWdOUHktOFZRUV9wZl8xZXU2M1dPNGszd1dkUFZsUzJMTXVMMEl3?oc=5", "source_name": "Community Impact", "published_at": "2024-08-23T07:00:00+00:00", "published_display": "23 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 79, "total_relevant": 47, "sentiment_summary": {"positive": 15, "negative": 2, "neutral": 30, "score": 56, "total": 47, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 14.3, "count": 26}, {"event": "earnings", "label": "Earnings", "weight": 9.35, "count": 17}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}], "positive_events": 15, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 28.18, "latest_week": "2026-07-10", "one_week_move": 0.2, "four_week_move": 8.0, "twelve_week_move": 31.1, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.447023, "market_dynamics_buy_signal": false, "relative_strength": 0.430193, "fair_value_gap": 30.3, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 45.4455, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.2% over one week, +8.0% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 55, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 8}, {"label": "TradingView", "count": 8}, {"label": "Market source", "count": 6}, {"label": "Simply Wall Street", "count": 5}, {"label": "Investing.com", "count": 4}, {"label": "GuruFocus", "count": 2}, {"label": "PR Newswire", "count": 2}, {"label": "dars.gov.et", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 47}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 26}, {"label": "Earnings", "count": 17}, {"label": "Balance sheet", "count": 2}, {"label": "Guidance", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "47", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+0.2% over one week, +8.0% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "BioLife Solutions (NASDAQ: BLFS) EVP has 516 shares withheld for taxes"}], "updated_at": "2026-07-16T04:34:41.437856+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}